{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New-Onset Seizure Activity in a Transplant Patient on Immunosuppressive Therapy

Activity Steps

Purpose of Activity

To review suggestions for the identification and management of posterior reversible encephalopathy syndrome (PRES), as illustrated by a detailed case study.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the etiology, differential diagnosis, and epidemiology of PRES.
  2. Select the applicable assessment, diagnostic, and prognostic approaches to PRES.
  3. Recognize pharmacologic approaches that should be considered or avoided when treating PRES.
Price: $12.95


  • AANP 1.2 CH / 0.4 APH
  • DC - BON 1.2 CH
  • FL - BON 1.0 CH
  • GA - BON 1.2 CH

This Activity is approved for 1.2 contact hour (s) of continuing education (which includes 0.4 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 20104586. This Activity was planned in accordance with AANP Accreditation Standards and Policies.

Awarded Advanced Pharmacology Hours

Test Code: JAANP1220
Published: Dec 2020
Expires: 12/1/2021
Required Passing Score: 14/18 (77%)
Authors: Kathryn Gersch, FNP-BC; Taylor R. Spencer, MD, MPH